See what questions
a doctor would ask.
A year after the FDA promised that consumer warnings would appear on the labels of a drug called Amiodarone, there has still been no action. One woman claims that her father died from pulmonary toxicity after taking Amiodarone to treat his atrial fibrillation. Amiodarone is not approved for use as treatment of atrial fibrillation. Amiodrone should only be a last resort treatment for certain heart conditions but findings indicate that it is being overprescribed (2 million unapproved prescriptions in the US) when safer options could be used. Some side effects of the drug have been death from lung and liver damage and blindness. Amiodarone is intended as a last choice drug to treat ventricular arrhythmias.
Source: summary of medical news story as reported by Medical News Today
About: Promised label warning on heart drug still not done after 1 year
Date: 27 November 2004
Source: Medical News Today
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City